Listerine actives need more plaque, gingivitis data to prove efficacy, FDA plaque subcmte.
This article was originally published in The Rose Sheet
Executive Summary
LISTERINE ACTIVES NEED ADDITIONAL GINGIVITIS, PLAQUE DATA TO PROVE EFFICACY, FDA's Dental Products Panel Plaque Subcommittee Chair Robert Genco, DDS/PhD, State University of New York-Buffalo, said at a May 8-9 meeting in Bethesda, Md. After hearing data from Warner-Lambert on the efficacy of the four active ingredients in 100-year old Listerine -- thymol (.064%), menthol (.042%), eucalyptol (.092%) and methyl salicylate, also known as wintergreen oil (.06%) -- Genco said the subcommittee needs additional data on the antiplaque and antigingivitis effect of the four actives.